Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06313073
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2024-02-26
Brief Title:
Neoadjuvant Radiotherapy for Breast Cancer
Sponsor:
Changhai Hospital
Organization:
Changhai Hospital
Study Overview
Official Title:
Neoadjuvant Radiotherapy Versus Adjuvant Radiotherapy for Breast Cancer A Phase II Exploratory Randomized Controlled Clinical Study
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to compare the effects of neoadjuvant radiotherapy and adjuvant radiotherapy in patients with breast cancer
The main questions it aims to answer are
The clinical effect of neoadjuvant radiotherapy for breast cancer was determined according to the postoperative specimens
Evaluate the acute and late toxicity of preoperative radiotherapy Participants will be randomly divided into two groups the neoadjuvant radiotherapy group and the adjuvant radiotherapy group
The main questions it aims to answer are
The clinical effect of neoadjuvant radiotherapy for breast cancer was determined according to the postoperative specimens
Evaluate the acute and late toxicity of preoperative radiotherapy Participants will be randomly divided into two groups the neoadjuvant radiotherapy group and the adjuvant radiotherapy group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None